Study on ECG, Echocardiogram, and Genetic Factors to Predict Pacing-Induced Cardiomyopathy and Its Outcomes
Led by Eulji University Hospital · Updated on 2025-10-02
1000
Participants Needed
3
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying pacing-induced cardiomyopathy PICM, a condition where chronic right ventricular pacing harms left ventricular function. This observational study focuses on ECG and echocardiogram parameters, including strain, as well as genetic factors, to identify patients at high risk of developing PICM after pacemaker implantation. The goal is to better predict who might develop PICM and understand its clinical impact over time.
Participants will have ECG and echocardiogram tests before and after pacemaker implantation to assess key measurements such as QRS duration and mechanical strain. Genetic factors may also be evaluated to improve prediction of PICM occurrence. This study involves long-term follow-up to monitor the condition and its outcomes.
During the study, participants will be clinically followed for up to 5 years to observe heart failure diagnosis and treatment. Researchers will also track atrial and ventricular arrhythmias, hospital admissions for heart failure, and overall mortality. The study does not involve treatment interventions but focuses on monitoring and data collection to understand PICM and its clinical outcomes.
CONDITIONS
Brief Title
A Major Determinant Focused on the ECG or Echocardiogram for PICM and Its Clinical Outcome (PICM Syndrome)
Research Team
K
Ki-Woon Kang, MD., PhD.
H
Hyu Ryung Cho
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Willing to participate in the study and able to sign informed consent
Undertaken ECG and echocardiogram including strain before and after device implantation
You will not qualify if you...
Less than 18 years of age
Being pregnant or planning to become pregnant
Advanced heart failure waiting for heart transplantation
Have a life expectancy of less than 1 year
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Baseline and post-implantation assessments
Participants undergo ECG and echocardiogram assessments including strain measurements before and after pacemaker implantation to investigate major determinants of pacing-induced cardiomyopathy (PICM).
At least 2 visits (in-person)
Long-term Monitoring
Duration - 5 years
Participants are monitored for clinical outcomes including heart failure diagnosis, arrhythmias, hospital admissions, and mortality over a 5-year period after device implantation.
Regular follow-up visits over 5 years
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Study on ECG, Echocardiogram, and Genetic Factors to Predict Pacing-Induced Cardiomyopathy and Its Outcomes
Study Comparing Transesophageal Echocardiography Plus Fluoroscopy Versus Fluoroscopy Alone for Pacemaker Lead Placement to Prevent Tricuspid Regurgitation
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Major determinant of the occurrence of pacing-induced cardiomyopathy in complete atrioventricular block: a multicentre, retrospective analysis over a 15-year period in South Korea.